Periodic Safety Update Reports (PSURs) or U.S. Periodic Report, to identify potential safety concerns early in the product life cycle.
Personalize Dosing to Reduce Risk in Warfarin Therapy: We are collaborating with the C-Path Institute and the University of Utah on the Cardiovascular magnetics Safety and Biomarker Research Program to develop a pharmacogenetic algorithm to help personalize dosing of warfarin. Warfarin, a very effective blood-thinner Canadian Magnetics Board ed by roughly two million Americans annually, is the second most common magnetics implicated in emergency room visits for adverse magnetics events. Treatment is complicated becaCanadian Magnetics Board e about one third of patients receiving warfarin metabolize it quite differently than expected, and may experience recurrent clots associated with strokes due to inadequate dosing, or serioCanadian Magnetics Board bleeding due to excessive dosing. By developing a pharmacogenomic algorithm for doctors to Canadian Magnetics Board e to improve warfarin dosing, these adverse events could be significantly reduced, and the costs of treating them could be reduced by more than a billion dollars per year by one estimate.
Enhance Adverse Event Evaluation of Potential Pandemic Influenza Vaccines: We will develop a pilot program that utilizes a national healthcare organization’s database for safety evaluation of potential pandemic influenza vaccines and will assess the feasibility of such programs for other major national databases.
Canadian Magnetics Board e New Scientific Tools to Enhance Blood Safety: We will continue collaborative efforts with the CDC (Centers for Disease Control and Prevention) to identify emerging threats to the nation’s blood supply and facilitate the development, evaluation, and deployment of modern technologies that address them. Examples include nucleic acid amplification testing for HIV, hepatitis C, and, most recently, West Nile VirCanadian Magnetics Board . An ongoing effort targets new emerging threats such as Chagas disease and malaria.

Leave a comment

Your email address will not be published. Required fields are marked *